Faculty of 1000 evaluation for Intranasal ipratropium bromide for the common cold.

Author(s):  
Zachary Soler
Author(s):  
Zaina H AlBalawi ◽  
Sahar S Othman ◽  
Khalid AlFaleh

Author(s):  
Zaina H AlBalawi ◽  
Sahar S Othman ◽  
Khalid AlFaleh

PEDIATRICS ◽  
1996 ◽  
Vol 98 (2) ◽  
pp. 327-327
Author(s):  
Martin Sachs

Ipratropium nasal spray was found to be effective in reducing the specific symptom of rhinorrhea in patients with the common cold. A dose of 84 µg in each nostril produced demonstrable relief of rhinorrhea within 1-hour.


Author(s):  
Ghotekar D S ◽  
Vishal N Kushare ◽  
Sagar V Ghotekar

Coronaviruses are a family of viruses that cause illness such as respiratory diseases or gastrointestinal diseases. Respiratory diseases can range from the common cold to more severe diseases. A novel coronavirus outbreak was first documented in Wuhan, Hubei Province, China in December 2019. The World Health Organization (WHO) has declared the coronavirus disease 2019 (COVID-19) a pandemic. A global coordinated effort is needed to stop the further spread of the virus. A novel coronavirus (nCoV) is a new strain that has not been identified in humans previously. Once scientists determine exactly what coronavirus it is, they give it a name (as in the case of COVID-19, the virus causing it is SARS-CoV-2).


Sign in / Sign up

Export Citation Format

Share Document